Navigation Links
Dr. Brad Vince, with Vince and Associates Clinical Research, Presents at the Exploratory Development World Congress 2009
Date:11/2/2009

OVERLAND PARK, Kan., Nov. 2 /PRNewswire/ -- Vince and Associates Clinical Research (VACR), a leading provider of Phase I-IV clinical research trials, announced that Dr. Bradley Vince, Medical Director and President, shared his expertise at the Exploratory Development World Congress on October 20, 2009 in Boston, Massachusetts. The Exploratory Development World Americas Congress focuses on early development strategy, including a wide range of disciplines within clinical trials including Clinical Research, Clinical Pharmacology, Phase I Trials, Exploratory Development, Regulatory Affairs, PK/PD and Clinical Operations.

The pre-conference workshop facilitated by Lorraine M. Rusch, PhD, Vice President of Business Development at VACR, was entitled Mitigating Risk in Early Clinical Development. During the session, Dr. Vince discussed Recruiting Strategies and Medical Oversight of Special Population Volunteers in Early Stage Trials. Dr. Vince related his physician perspective on the recruitment and medical management of intent-to-treat populations during early clinical research trials which enable earlier Proof of Concept (POC) drug development data to be successfully obtained.

"As a multi-specialty research unit, Vince and Associates Clinical Research is a leading provider of Phase I-IV clinical research for the pharmaceutical and biotechnology industry," said Dr. Vince. "We welcomed the opportunity to share our perspective, medical expertise and strength in early-stage drug development data at the Exploratory Development World Congress."

As the Medical Director of the Vince and Associates Clinical Research, Dr. Vince provides overall management of Phase I-IV clinical pharmacology services, including study design, feasibility, recruiting and monitoring of both healthy normal subjects and special population patients participating in clinical trials at the Overland Park, Kansas facilities.

Vince and Associat
'/>"/>

SOURCE Vince and Associates Clinical Research
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Vincent W. Renz Joins NewCardio as President
2. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
3. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Bioniche Life Sciences Inc.
4. Tata Interactive Systems Partners With Bersin & Associates for Exclusive Executive Learning Forum - TLF 2009
5. Physiotherapy Associates Marks National Physical Therapy Month With Free Educational Brochure
6. Aprimas EHR Helps Bend Urology Associates Improve Efficiency, Workflow
7. Press Ganey Partners With Health Management Associates
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
10. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
11. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... LAWRENCE, Mass., Dec. 15 OBP Medical ... comfort and overall patient satisfaction in hospitals. ,, ... measuring the positive effects of OBP Medical,s Under ... hospital stay. A hospital wide survey is comparing ... of their stay while wearing Under Johnnies(TM) against ...
(Date:12/14/2009)... Fujirebio Diagnostics Inc., a Malvern-based diagnostics ... Year by the Eastern Technology Council at a ... Philadelphia on Thursday, December 3, 2009. ... region,s largest technology and life sciences trade association. ... and Life Sciences Community, the awards are a ...
(Date:12/14/2009)... WASHINGTON, Dec. 14 Following is a ... the Consumer Healthcare Products Association (CHPA), regarding today,s ... (NIDA,s) Monitoring the Future survey: ,, "Findings released ... speak to the need for continued efforts to ... need to talk to their teens about medicine ...
Breaking Medicine Technology:Under Johnnies(TM) Proven To Increase Patient Satisfaction by OBP Medical Inc. 2Fujirebio Diagnostics Named Life Sciences Company of the Year 2Statement From the Consumer Healthcare Products Association(CHPA) on Annual Monitoring the Future Survey on Drug Abuse 2Statement From the Consumer Healthcare Products Association(CHPA) on Annual Monitoring the Future Survey on Drug Abuse 3Drug Combo May Offer Best Relief for Nerve Pain 58527 1Drug Combo May Offer Best Relief for Nerve Pain 58527 2Australian study sheds light on kidney repair and disease 10181 1Australian study sheds light on kidney repair and disease 10181 2Cardinal Health Foundation Invites Health Care Providers to Apply for 241 Million in Grants to Improve Efficiency Quality of Care 58524 1Cardinal Health Foundation Invites Health Care Providers to Apply for 241 Million in Grants to Improve Efficiency Quality of Care 58524 2
... Feb. 5 Joseph F. Finn, Jr.,CPA, the Assignee ... The Committee for Orphan Drug Products of the European ... for the,prevention of oral mucositis (OM) in head and ... mucositis during radiation therapy of head and,neck cancers is ...
... Calif., Feb. 5 Alexza,Pharmaceuticals, Inc. (Nasdaq: ... Phase 1 clinical trial with AZ-007 (Staccato(R) zaleplon). ... the treatment of insomnia,patients who have difficulty falling ... the night and have difficulty falling back asleep. ...
Other Medicine Technology:ActivBiotics Receives Orphan Drug Designation from the European Medicines Agency for Superoxide Dismutase Mimetic, M40403, in Oral Mucositis Indication 2ActivBiotics Receives Orphan Drug Designation from the European Medicines Agency for Superoxide Dismutase Mimetic, M40403, in Oral Mucositis Indication 3Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status 2Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status 3Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status 4Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status 5Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status 6Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status 7
(Date:12/15/2009)... and Spanish scientists have found the first potential immunological ... infected by the pandemic H1N1 virus. , The ... hospitalized patients, 15 outpatients and 15 control subjects in ... July and August 2009. Researchers from the Hospital Clinico ... Network found high levels of a molecule called interleukin ...
(Date:12/15/2009)... Although seen as a potential heart disease therapy, ... of a transfer protein may not be effective, a ... Human Nutrition Research Center on Aging (USDA HNRCA) at ... found an association between low plasma cholesterol ester transfer ... in the Framingham Heart Study population. , CETP is ...
(Date:12/15/2009)... to control the volume without compromising sound-quality or comfort. ... ... 2009 -- EarPeace ( www.earpeace.com ) is redefining hearing protection ... three different skin-tone colors. "As a big fan of live-music ... was looking for a way to continue my active lifestyle ...
(Date:12/15/2009)... Workers, Compensation Carrier Confirms PMSI as Solution Provider of ... ... Tampa, FL (Vocus) December 15, 2009 -- PMSI, one ... of specialty products and services for the workers’ compensation ... has decided to renew its pharmacy services (retail and ...
(Date:12/15/2009)... Fillers and Large Volume Injections Dangerous , ... ... The popularity and hype surrounding buttock augmentation and other large-volume ... U.S. borders is an alarming and potentially deadly trend, cautions ... fillers such as polymethylmethacrylate (PMMA), silicone, and polyacrylimide used in ...
Breaking Medicine News(10 mins):Health News:First immunological clue to why some H1N1 patients get very ill or die 2Health News:Low cholesterol transfer protein activity associated with heart disease risk 2Health News:EarPeace Introduces Elegant, High-fidelity Hearing Protection Solution 2Health News:KEMI Renews Contract With PMSI 2Health News:Physicians Coalition for Injectable Safety Warns Buttock-Boosting Injections Risky and Deadly 2Health News:Physicians Coalition for Injectable Safety Warns Buttock-Boosting Injections Risky and Deadly 3Health News:Physicians Coalition for Injectable Safety Warns Buttock-Boosting Injections Risky and Deadly 4
... Researchers have found a gene variant that raises a ... and painful condition attributed to inflammation of the gastrointestinal ... earlier results of a German study that identified the ... the disease.Crohns disease is a chronic and painful condition ...
... Changes to the UK licensing laws have trebled the number ... reveals research in Emergency Medicine Journal . ,The ... the clock, took effect in November 2005. ,The ... of binge drinking and associated crime and disorder, and boost ...
... has revealed that the star had a miscarriage in 2005 . ... Kutcher ever since they tied the knot in September 2005, and ... Ghost star did in fact become pregnant, but she lost the ... have kids of her own. Demi and Ashton have been trying ...
... Paul McCartney for his decision to boycott cancer charities that ... has supported cancer charities since his first wife Linda died ... planning to decline financial support to organisations that practice vivisection. ... discovering that a number of charities close to his heart ...
... belief that male circumcision can reduce HIV infection rates ... will be told next week . ,David ... conference to be held in Sydney from July 22-25, ... in HIV prevention. ,"We always knew that ...
... an alarming depletion of ground water levels in the country ... of water table. ,The Central Groundwater Board ... water level at various places across the country and identified ... this score, a senior official said. ,"The constant ...
Other Medicine News:Health News:Gene Variants for Crohn's Disease Identified 2Health News:Gene Variants for Crohn's Disease Identified 3Health News:UK Licensing Law Changes Have Trebled Overnight Alcohol Related Visits to Emergency Care 2Health News:Male Circumcision can Cut HIV Infection, Studies Show 2Health News:Groundwater Levels Depleting Alarmingly in India 2
... 5mm AEM Laparoscopic Instruments incorporate a layered ... are shielded and monitored to prevent stray ... instrument caused by insulation failure or capacitive ... protective shield built into all AEM Instruments ...
... AEM Laparoscopic Instruments incorporate a layered design ... shielded and monitored to prevent stray electrosurgical ... caused by insulation failure or capacitive coupling; ... shield built into all AEM Instruments provides ...
... Instruments incorporate a layered design unique in ... monitored to prevent stray electrosurgical burns along ... insulation failure or capacitive coupling; a well-documented ... into all AEM Instruments provides a neutral ...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
Medicine Products: